These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6800030)

  • 1. [Lipid changes as a possible risk factor in preclinical hypothyroidism. Preliminary report].
    Gräni R; Staub JJ; Noelpp B; Stähelin HB; Oberhänslin A
    Schweiz Med Wochenschr; 1981 Dec; 111(49):1906-7. PubMed ID: 6800030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of serum thyroid stimulating hormone and serum lipids and lipoproteins in patients with suspected hypothyroidism.
    Gomo Z; Ascott MB
    Cent Afr J Med; 1994 Apr; 40(4):94-8. PubMed ID: 7954717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LDL/HDL-changes in subclinical hypothyroidism: possible risk factors for coronary heart disease.
    Althaus BU; Staub JJ; Ryff-De Lèche A; Oberhänsli A; Stähelin HB
    Clin Endocrinol (Oxf); 1988 Feb; 28(2):157-63. PubMed ID: 3168304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thyroid hormones and thyroid reserve in preclinical hypothyroidism].
    Noelpp B; Staub JJ; Heinimann T; Gräni R; Girard J
    Schweiz Med Wochenschr; 1981 Dec; 111(49):1904-5. PubMed ID: 6800029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromsø Study.
    Iqbal A; Jorde R; Figenschau Y
    J Intern Med; 2006 Jul; 260(1):53-61. PubMed ID: 16789979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid measurements for coronary risk assessment: a review.
    Berg LH
    Am J Med Technol; 1981 Jul; 47(7):539-43. PubMed ID: 7025628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease.
    De Rosa G; Testa A; Giacomini D; Carrozza C; Maussier ML; Valenza V; D'Errico GF
    Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues.
    Staub JJ; Althaus BU; Engler H; Ryff AS; Trabucco P; Marquardt K; Burckhardt D; Girard J; Weintraub BD
    Am J Med; 1992 Jun; 92(6):631-42. PubMed ID: 1605145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and correction of hypothyroidism in a large cohort of patients referred for dyslipidemia.
    Diekman T; Lansberg PJ; Kastelein JJ; Wiersinga WM
    Arch Intern Med; 1995 Jul; 155(14):1490-5. PubMed ID: 7605150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are thyroid peroxidase antibodies associated with cardiovascular disease risk in patients with subclinical hypothyroidism?
    Wells BJ; Hueston WJ
    Clin Endocrinol (Oxf); 2005 May; 62(5):580-4. PubMed ID: 15853828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subclinical hypothyroidism in obese patients: relation to resting energy expenditure, serum leptin, body composition, and lipid profile.
    Tagliaferri M; Berselli ME; Calò G; Minocci A; Savia G; Petroni ML; Viberti GC; Liuzzi A
    Obes Res; 2001 Mar; 9(3):196-201. PubMed ID: 11323445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma viscosity, an early cardiovascular risk factor in women with subclinical hypothyroidism.
    Erdem TY; Ercan M; Ugurlu S; Balci H; Acbay O; Gundogdu S
    Clin Hemorheol Microcirc; 2008; 38(4):219-25. PubMed ID: 18334776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sub-biochemical hypothyroidism: an exaggerated thyroid stimulating hormone response to thyrotrophin releasing hormone.
    Sheth JJ; Thakore PB; Trivedi BB; Shah NN; Vaidya RA
    J Assoc Physicians India; 1999 Mar; 47(3):275-9. PubMed ID: 10999119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [High-density lipoproteins in children with coronary diseases].
    Oberhänsli I; Pometta D; Micheli H; Raymond L
    Helv Paediatr Acta; 1981; 36(2):135-47. PubMed ID: 7251385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation response and effectiveness of thyroid hormone replacement treatment on lipid profile and function in elderly patients with subclinical hypothyroidism.
    Arinzon Z; Zuta A; Peisakh A; Feldman J; Berner Y
    Arch Gerontol Geriatr; 2007; 44(1):13-9. PubMed ID: 16621071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular risk factors in middle-aged women with subclinical hypothyroidism.
    Luboshitzky R; Herer P
    Neuro Endocrinol Lett; 2004 Aug; 25(4):262-6. PubMed ID: 15361814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of serum total thyroxine, triiodothyronine, free thyroxine, and thyrotropin concentrations for diagnosis of hypothyroidism in dogs.
    Peterson ME; Melián C; Nichols R
    J Am Vet Med Assoc; 1997 Dec; 211(11):1396-402. PubMed ID: 9394888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Various lipoprotein fractions and their relation to ischemic heart disease].
    Palazzuoli V; Mondillo S; Kristodhullu A; De Stefano R; Amatucci G
    G Ital Cardiol; 1983; 13(2):90-4. PubMed ID: 6884650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.